Photo courtesy of Hey Jane
Kiki Freedman is the co-founder and CEO of Hey Jane, a U.S. healthcare company providing abortion-related and reproductive telehealth services. In 2025, she expanded Hey Jane’s offerings to reach more patients across more states, improving access to affordable, stigma-free care.
A strong advocate for medication abortion, Freedman spoke out following the FDA’s approval of generic mifepristone, emphasizing its importance for women facing difficult decisions amid growing political threats.
Under her leadership, Hey Jane continued its partnership with the National Network of Abortion Funds, launching a campaign that raised $10,000 for abortion care. In 2025, the company celebrated serving its 100,000th patient and reported a 164% increase in telehealth use since Roe v. Wade was overturned.
